In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

DCGI suspends Entod Pharma`s eye drop permission for presbyopia treatment due to unapproved claims. The company will ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for ...

The Central Drugs Standard Control Organisation (CDSCO) said that it was suspending its approval for the pilocarpine ...

In an order issued on September 10, the Drugs Controller General of India (DCGI) said the Directorate had issued permission ...

The company, which was aiming for an October launch in the Indian market, said that it will challenge the suspension in court ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

According to the National Eye Institute, presbyopia is a refractive error that makes it hard for middle-aged and older adults ...

Days after Mumbai-based Entod Pharmaceuticals' claimed that their new eye drops could reduce the need for reading glasses in ...

DCGI suspends permission of Entod Pharma's ophthalmic solution PresVu: Our Bureau, New Delhi Wednesday, September 11, 2024, 17:20 Hrs [IST] The Central drug regulator has suspende ...

On September 4, the drug regulator had asked for an explanation from the company for the claims it made in the press following which the drug-maker also submitted its response.

The claims made by Entod Pharmaceuticals about PresVu eye drops came under scrutiny for being unapproved and potentially misleading. According to the suspension order copy accessed by News18, the ...